Physician profile
Steven Lee
NPI 1992877427
$1,304.05
in general payments reported to CMS, 2019-2025
13 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.88 · 2021: $117 · 2022: $178 · 2023: $270 · 2024: $211 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $617.06 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Baxter Healthcare | $146.46 | 2024 | |
| Amgen INC. | $120.17 | 2025 | Uplizna |
| Axogen | $95.30 | 2023 | Avance Nerve Graft |
| Astrazeneca Pharmaceuticals LP | $58.84 | 2019-2021 | |
| Genzyme Corporation | $57.70 | 2022-2025 | |
| Optinose US, INC. | $46.12 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.62 | 2025 | |
| Integra Lifesciences Corporation | $24.91 | 2022 | |
| Merck Sharp & Dohme LLC | $22.80 | 2023 | |
| Alk-Abello, INC | $21.05 | 2023 | Odactra, Ragwitek, Grastek |
| Acclarent, INC | $18.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.